You are in: Caribbean
Change location

You are here

Journal > Clinical Medicine

Disable VAT on Taiwan

Unfortunately, as of 1 January 2020 SAGE Ltd is no longer able to support sales of electronically supplied services to Taiwan customers that are not Taiwan VAT registered. We apologise for any inconvenience. For more information or to place a print-only order, please contact uk.customerservices@sagepub.co.uk.

Bladder Cancer

Bladder Cancer

Published in Association with IOS Press
Published in Association with official journal of the Bladder Cancer Advocacy Network (BCAN)
eISSN: 23523735 | ISSN: 23523727
Download flyer Recommend to Library

Bladder Cancer is an international multidisciplinary journal aiming to facilitate progress in understanding the epidemiology, etiology, molecular genetics, pathogenesis, pathobiology and pharmacology of tumors of the bladder and upper urinary tract with the objective of improving diagnosis, treatment and survivorship in patients.

The journal is directed primarily at researchers and clinicians working on these areas, with some content aimed at patients/patient advocates with these conditions. With this objective in mind, the journal publishes original research reports, systematic and regular reviews, short communications, and letters-to-the-editor in basic science, translational research and clinical medicine. The journal is committed to the highest ethical standards and best practices, and prospective authors are encouraged to consult the relevant author instructions and policies on the website at the time of submission as these are updated regularly to reflect changing guidelines.

Submit your manuscript today at https://mc.manuscriptcentral.com/bladdercancer.

Bladder Cancer is an international multidisciplinary journal aiming to facilitate progress in understanding the epidemiology, etiology, molecular genetics, pathogenesis, pathobiology and pharmacology of tumors of the bladder and upper urinary tract with the objective of improving diagnosis, treatment and survivorship in patients. The journal is directed primarily at researchers and clinicians working on these areas, with some content aimed at patients/patient advocates with these conditions. With this objective in mind, the journal publishes original research reports, systematic and regular reviews, short communications, and letters-to-the-editor in basic science, translational research and clinical medicine. The journal is committed to the highest ethical standards and best practices, and prospective authors are encouraged to consult the relevant author instructions and policies on the website at the time of submission as these are updated regularly to reflect changing guidelines.

Editors-in-Chief
Seth P. Lerner Baylor College of Medicine, USA
Dan Theodorescu Samuel Oschin Comprehensive Cancer Institute, USA
Associate Editors for Reviews
Andrea B. Apolo National Cancer Institute, USA
Jeremy Teoh The Chinese University of Hong Kong, China
Associate Editor of Challenging Cases in Urothelial Cancer
Mark S. Soloway Memorial Healthcare System, USA
Associate Editors of Clinical Trials Corner
Piyush K. Agarwal University of Chicago Medicine, USA
Cora N. Sternberg San Camillo and Forlanini Hospitals, Italy
Editor of Paper Alert
Edward M. Messing University of Rochester Medical Center, USA
Associate Editors
Alexandre R. Zlotta 1. Lunenfeld-Tanenbaum Research Institute 2. Princess Margaret Cancer Centre, Canada
Xue-Ru Wu New York University, USA
Bas W.G. van Rhijn Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Netherlands
George Thalmann University of Bern, Switzerland
Gottfrid Sjödahl Lund University, Sweden
John P. Sfakianos Icahn School of Medicine at Mount Sinai, USA
Maria J. Ribal Hospital Clinic. University of Barcelona, Spain
Francisco X. Real CNIO (Spanish National Cancer Research Centre), Spain
Valeria Panebianco University of Rome La Sapienza, Italy
Matt Milowsky University of North Carolina Lineberger Comprehensive Cancer Center, USA
David McConkey Johns Hopkins Greenberg Bladder Cancer Institute and Brady Urological Institute, USA
Surena F. Matin University of Texas MD Anderson Cancer Center, USA
S. Bruce Malkowicz Hospital of the University of Pennsylvania, USA
Yair Lotan UT Southwestern Medical Center, USA
William Y. Kim University of North Carolina, USA
Anne Kiltie University of Aberdeen, UK
Rebecca Johnson Bladder Cancer Advocacy Network (BCAN), USA
Arndt Hartmann University Erlangen-Nürnberg, Germany
Donna Hansel The University of Texas MD Anderson Cancer Center, USA
Thomas Flaig University of Colorado, USA
Jason A. Efstathiou Massachusetts General Hospital, USA
Lars Dyrskjøt Aarhus University, Denamrk
David J. DeGraff Pennsylvania State University College of Medicine, USA
Karim Chamie University of California Los Angeles, USA
Joaquim Bellmunt Beth Israel Deaconess Medical Center, USA
Hikmat Al-Ahmadie Memorial Sloan-Kettering Cancer Center, USA
Social Media Editor
Bishoy M. Faltas Weill Cornell Medicine, USA
Assistant Social Media Editor
Weisi Liu Weill Cornell Medicine, USA
Editorial Board Members
Cory Abate-Shen Columbia University Medical Center, USA
Phillip Abbosh Temple University Hospital, USA
Marco A. Arap The University of São Paulo, Brazil
Marko Babjuk Motol University Hospital, Czech Republic
Leslie K. Ballas Cedars-Sinai Medical Center, USA
Rick Bangs Patient Advocate, USA
Trinity Bivalacqua Johns Hopkins Medicine, USA
Peter Black University of British Columbia, Canada
Bernard Bochner Memorial Sloan-Kettering Cancer Center, USA
James Catto The University of Sheffield, UK
Keith Syson Chan Samuel Oschin Comprehensive Cancer Institute, USA
Sam S. Chang Vanderbilt University Medical Center, USA
Liang Cheng Indiana University, USA
Bogdan Czerniak University of Texas MD Anderson Cancer Center, USA
Dan Petrylak Yale University, USA
Garrett M. Dancik Eastern Connecticut State University, USA
Sia Daneshmand University of Southern California, USA
Ian D. Davis Monash University, Australia
Maria De Santis Charité University Hospital, Germany
Colin P.N. Dinney University of Texas MD Anderson Cancer Center, USA
Mario I. Fernández Cínica Alemana Universidad del Desarrollo, Chile
Eliney Ferreira Faria Hospital Felicio Rocho, Brazil
Georgios Gakis University Hospital of Halle, Germany
Matt Galsky Tisch Cancer Institute, USA
Scott Gilbert H. Lee Moffitt Cancer Center & Research Institute, USA
Peter J. Goebell Universitätsklinikum Erlangen, Germany
John Gore University of Washington, USA
Christian Gratzke University Hospital Freiburg, Germany
Sounak Gupta Mayo Clinic, USA
Noah Hahn Johns Hopkins University School of Medicine, USA
Richard Hautmann Universität Ulm, Germany
Jean Heather Hoffman-Censits Johns Hopkins University, USA
Jer-Tsong Hsieh UT Southwestern Medical Center, USA
Molly Ingersoll Institut Pasteur, France
Ashish Kamat University of Texas MD Anderson Cancer Center, USA
Lawrence Karsh The Urology Center of Colorado, USA
Wassim Kassouf McGill University Health Center, Canada
Lambertus Kiemeney Radboud University Medical Center, Netherlands
Deborah W. Knapp Purdue University, USA
Margaret Knowles Leeds Institute of Cancer & Pathology, UK
Badrinath Konety University of Minnesota, USA
David Kwiatkowski Brigham and Women's Hospital- Harvard Medical School, USA
Donald Lamm University of Arizona, USA
Nathan Lawrentschuk University of Melbourne, Australia
Cheryl Lee University of Michigan Hospitals, USA
Vinata Lokeshwar Augusta University Medical College of Georgia, USA
Moritz Maas University Hospitals Tübingen, Germany
Nuria Malats CNIO (Spanish National Cancer Research Centre), Spain
Kazumasa Matsumoto Kitasato University, Japan
James McKiernan Columbia University, USA
Reza Mehrazin The Mount Sinai Hospital, USA
Maxwell Meng University of California San Francisco, USA
Timur Mitin Oregon Health and Science University, USA
Anirban Mitra Cedars-Sinai Medical Center, USA
Ofer Nativ Bnai Zion Medical Center, Israel
Roman Nawroth Technical University of Munich, Germany
Matthew Nielsen School of Medicine, USA
Hiroyuki Nishiyama University of Tsukuba, Japan
Mike O'Donnell University of Iowa Carver College of Medicine, USA
Joan Palou Redorta Universitat Autonoma De Barcelona, Spain
Kamal Pohar Ohio State University, USA
Michael Porter University of Washington, USA
Ludmila Prokunina-Olsson National Cancer Institute, USA
Sarah P. Psutka University of Washington, USA
Nagireddy Putluri Baylor College of Medicine, USA
François Radvanyi Institut Curie, France
Derek Raghavan Levine Cancer Institute, USA
Leonardo O. Reis University of Campinas, Brazil
Cyrill Rentsch University Hospital Basel, Switzerland
Jonathan Rosenberg Memorial Sloan-Kettering Cancer Center, USA
Arthur Sagalowsky UT Southwestern Medical Center, USA
Marta Sanchez-Carbayo University of the Basque Country, Spain
Bernd Schmitz-Drager Friedrich-Alexander University, Germany
Mark Schoenberg The Albert Einstein College of Medicine, USA
Shahrokh F. Shariat Medical University Vienna, Austria
Parminder Singh Mayo Clinic Arizona, USA
Eila C. Skinner Stanford University, USA
Angela B Smith UNC-Chapel Hill School of Medicine, USA
Steven C. Smith Virginia Commonwealth University, USA
Gary Steinberg Rush University Medical Center, USA
Arnulf Stenzl Universitätsklinikum Tübingen, Germany
Seth Strope Baptist MD Anderson Cancer Center, USA
Hyun Hwan Sung Samsung Medical Center, Korea
Robert Svatek UT Health Science Center San Antonio, USA
Jennifer M. Taylor Baylor College of Medicine, USA
John A. Taylor University of Kansas Medical Center, USA
Mark Tyson Mayo Clinic in Arizona, USA
Antonia Vlahou Biomedical Research Foundation Academy of Athens, Greece
Alfred Witjes Radboud University Nijmegen, Netherlands
Diane Zipursky Quale Bladder Cancer Advocacy Network (BCAN), USA
Tahlita C.M. Zuiverloon Erasmus MC Cancer Institute, Netherlands
Statistical and Bioinformatics Editorial Board
Michael C. Sachs Karolinska Institute, Sweden
Jeremy Taylor University of Michigan, USA
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Directory of Open Access Journals (DOAJ)
  • PubMed Central (PMC)